In post-bariatric patients who may already experience gastrointestinal sensitivity, gradual dose titration is particularly important
The stomach lining's vulnerability during GLP-1 therapy creates a window of heightened risk
With Ozempic (and Wegovy ): Digestive issues such as nausea, vomiting, diarrhea, constipation, or stomach pain are common when starting or increasing the dose
Furthermore, our analysis identified several potentially novel safety signals that warrant further investigation: Acute kidney injury (n = 675
Common allergens such as wheat, corn, soy, yeast, and dairy are avoided unless otherwise specified on the label